Calls for Proposals Early-stage Female Overseas FY 2022 Infectious Diseases and Immunology Research: U.S.-Japan Cooperative Medical Sciences Program Collaborative Awards

Outline

Status of Grants/Funding Opportunities Grants/Funding Opportunities
R&D phase Basic Study, Applied Study, Nonclinical Study/Pre-clinical Study, Clinical Study, Clinical Research
Key Fields Innovation and Clinical Research Center Project, Infectious disease
Submission Deadline 07/31/22 Sun
Title and Abstract Submission; health"AT"crdfglobal.org (Replace "AT" with "@")
Thursday July 7, 2022 (23:59) U.S. Eastern Time (ET) (UCT-4)
Full Proposal Submission; https://crdfglobal.fluxx.io/dashboard/index
Saturday, July 30, 2022 (23:59) U.S. Eastern Time (ET) (UCT-4)
e-Rad submission; https://www.e-rad.go.jp/
Sunday, July 31, 2022 (13:00) Japan Standard Time (JST)
Contact
Department of International Strategy, Division of International Strategy
Address: 23F Yomiuri Shimbun Bldg, 1-7-1, Otemachi, Chiyoda-ku, Tokyo, 100-0004 Japan
TEL: +81-3-6870-2216
E-mail: nichibei“AT”amed.go.jp (Replace “AT” with “@”)
Remarks:
Inquiries by email are strongly encouraged.

Public offering content

Japan Agency for Medical Research and Development (AMED), in collaboration with U.S. National Institute of Allergy and Infectious Diseases (NIAID), is pleased to announce the joint request for proposals on "Infectious Diseases and Immunology Research: US-Japan Cooperative Medical Sciences Program Collaborative Awards, 2022."

Awardees are expected to present their achievements at International Conference on Emerging Infectious Diseases in the Pacific Rim after 2023.

(1) Research areas
Infectious Diseases and Immunology
(2) Project size
60,000 USD
AMED needs to contract with the Japan sub teams in every fiscal year. 50 % of the total research budget is granted in JFY 2022, and of the research budget (50%) is granted in 2nd fiscal year, in JFY 2023.
(3) Research period
JFY 2022~JFY 2023
(4) Number of projects to be awarded
0-5 projects (expected)

For details please refer to the complete Request for Proposals.

Program summary

Overview of US-Japan Cooperative Medical Sciences Program

The US-Japan Cooperative Medical Sciences Program (USJCMSP), one of the oldest bilateral programs in the history of, was established in 1965 (under a U.S. Presidential-Japan Prime Ministerial level agreement) to strengthen Japanese research capacity and address issues of public health importance in the Asia Pacific region. The program continues to maintain its value as a unique tool to foster U.S., Japan, and Asia Pacific Region research collaboration. For more

Eligibility

  • Collaborative research teams consisting of investigators from (1) Japan and the U.S. , or (2) Japan, the U.S., and other Asia Pacific countries, are eligible to apply.
  • On each application both of the Japanese sub-team and the U.S sub team must include as a PI an early-stage or female investigator.

For complete eligibility requirements, please refer to the Request for Proposals.

Solicitation Period

04/27/22 Wed - 07/31/22 Sun
Title and Abstract Submission; health"AT"crdfglobal.org (Replace "AT" with "@")
Thursday July 7, 2022 (23:59) U.S. Eastern Time (ET) (UCT-4)
Full Proposal Submission; https://crdfglobal.fluxx.io/dashboard/index
Saturday, July 30, 2022 (23:59) U.S. Eastern Time (ET) (UCT-4)
e-Rad submission; https://www.e-rad.go.jp/
Sunday, July 31, 2022 (13:00) Japan Standard Time (JST)

In addition to the submission through CRDF Global on Saturday, July 30, 2022 (23:59) (USA), applicants to AMED are required to complete e-Rad submission no later than Sunday, July 31, 2022 (13:00) Japan Standard Time (JST).

How to Apply

To apply, please follow the information on the Request for Proposals and the AMED Supplemental Application Guideline for Japanese Sub-teams (in Japanese).

Reference

04/27/22

Last updated 04/27/22